Reungwetwattana T, Cho BC, Lee KH, Pang YK, et al. Lazertinib Versus Gefitinib Tyrosine Kinase Inhibitors in Treatment-Naive Patients With EGFR-Mutated Advanced NSCLC: Analysis of the Asian Subpopulation in LASER301. J Thorac Oncol 2023;18:1351-1361.
PMID: 37702629